These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 38791617)
1. A Preliminary Evaluation of the Prognostic Role of HER-2 and HER-3 Immunohistochemical Expression in Canine Melanomas. Parisi F; Aurisicchio L; Pecorari A; Poli A; Millanta F Animals (Basel); 2024 May; 14(10):. PubMed ID: 38791617 [TBL] [Abstract][Full Text] [Related]
2. Molecular and Immunohistochemical Expression of LTA4H and FXR1 in Canine Oral Melanoma. Nordio L; Bazzocchi C; Genova F; Serra V; Longeri M; Franzo G; Rondena M; Stefanello D; Giudice C Front Vet Sci; 2021; 8():767887. PubMed ID: 34966807 [TBL] [Abstract][Full Text] [Related]
3. Immunoexpression of S100A4 in canine skin melanomas and correlation with histopathological parameters. Grandi F; Rocha RM; Miot HA; Cogliati B; Rocha NS Vet Q; 2014; 34(2):98-104. PubMed ID: 25023931 [TBL] [Abstract][Full Text] [Related]
4. Association of vascular endothelial growth factor expression with patohistological parameters of cutaneous melanoma. Gacević M; Jović M; Zolotarevski L; Stanojević I; Novaković M; Miller K; Šuljagić V; Mijušković Ž; Vojvodić D Vojnosanit Pregl; 2016 May; 73(5):449-57. PubMed ID: 27430109 [TBL] [Abstract][Full Text] [Related]
5. Canine cutaneous melanocytic tumours: significance of β-catenin and survivin immunohistochemical expression. Bongiovanni L; D'Andrea A; Porcellato I; Ciccarelli A; Malatesta D; Romanucci M; Della Salda L; Mechelli L; Brachelente C Vet Dermatol; 2015 Aug; 26(4):270-e59. PubMed ID: 25962968 [TBL] [Abstract][Full Text] [Related]
6. Diverse roles of epidermal growth factors receptors in oral and cutaneous canine melanomas. Veloso ES; Gonçalves INN; Silveira TL; Oliveira FS; Vieira DS; Cassali GD; Del Puerto HL; Ferreira E BMC Vet Res; 2020 Jan; 16(1):24. PubMed ID: 31996230 [TBL] [Abstract][Full Text] [Related]
7. Isolation and characterization of two canine melanoma cell lines: new models for comparative oncology. Segaoula Z; Primot A; Lepretre F; Hedan B; Bouchaert E; Minier K; Marescaux L; Serres F; Galiègue-Zouitina S; André C; Quesnel B; Thuru X; Tierny D BMC Cancer; 2018 Dec; 18(1):1219. PubMed ID: 30514258 [TBL] [Abstract][Full Text] [Related]
8. E-Cadherin Expression in Canine Melanocytic Tumors: Histological, Immunohistochemical, and Survival Analysis. Silvestri S; Porcellato I; Mechelli L; Menchetti L; Iussich S; De Maria R; Sforna M; Bongiovanni L; Brachelente C Vet Pathol; 2020 Sep; 57(5):608-619. PubMed ID: 32578507 [TBL] [Abstract][Full Text] [Related]
9. Marginal and joint distributions of S100, HMB-45, and Melan-A across a large series of cutaneous melanomas. Viray H; Bradley WR; Schalper KA; Rimm DL; Gould Rothberg BE Arch Pathol Lab Med; 2013 Aug; 137(8):1063-73. PubMed ID: 23899062 [TBL] [Abstract][Full Text] [Related]
10. Inducible nitric oxide synthase expression in benign and malignant cutaneous melanocytic lesions. Massi D; Franchi A; Sardi I; Magnelli L; Paglierani M; Borgognoni L; Maria Reali U; Santucci M J Pathol; 2001 Jun; 194(2):194-200. PubMed ID: 11400148 [TBL] [Abstract][Full Text] [Related]
11. Cyclooxygenase-2 expression is associated with infiltration of inflammatory cells in oral and skin canine melanomas. Silveira TL; Veloso ES; Gonçalves INN; Costa RF; Rodrigues MA; Cassali GD; Del Puerto HL; Pang LY; Argyle DJ; Ferreira E Vet Comp Oncol; 2020 Dec; 18(4):727-738. PubMed ID: 32323423 [TBL] [Abstract][Full Text] [Related]
12. Diagnosis and Prognosis of Canine Melanocytic Neoplasms. Smedley RC; Sebastian K; Kiupel M Vet Sci; 2022 Apr; 9(4):. PubMed ID: 35448673 [TBL] [Abstract][Full Text] [Related]
13. Canine and feline uveal melanocytic tumours: Histologic and immunohistochemical characteristics of 32 cases. Moreira MVL; Langohr IM; Campos MRA; Ferreira E; Carvalho B; Blume GR; Montiani-Ferreira F; Ecco R Vet Med Sci; 2022 May; 8(3):1036-1048. PubMed ID: 35122675 [TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical characterization and evaluation of prognostic factors in canine oral melanomas with osteocartilaginous differentiation. Sánchez J; Ramirez GA; Buendia AJ; Vilafranca M; Martinez CM; Altimira J; Navarro JA Vet Pathol; 2007 Sep; 44(5):676-82. PubMed ID: 17846240 [TBL] [Abstract][Full Text] [Related]
19. Comparative investigation of cell cycle and immunomodulatory genes in mucosal and cutaneous melanomas: Preliminary data suggest a potential promising clinical role for p16 and the PD-1/PD-L1 axis. Wrede N; Hoffmann I; Vollbrecht C; Koch I; Wolkenstein P; Klauschen F; Capper D; von Laffert M; Jurmeister P Pathol Res Pract; 2022 Jan; 229():153689. PubMed ID: 34844086 [TBL] [Abstract][Full Text] [Related]
20. Expression of melanocytic differentiation markers in malignant melanomas of the oral and sinonasal mucosa. Prasad ML; Jungbluth AA; Iversen K; Huvos AG; Busam KJ Am J Surg Pathol; 2001 Jun; 25(6):782-7. PubMed ID: 11395556 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]